Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

Susumu Ikehara

Susumu Ikehara

Hirakata City, Osaka 570-1010

  • Short Communication
    Advances in Leukemia Treatment with Bone Marrow Transplantation
    Author(s): Susumu IkeharaSusumu Ikehara

    Bone Marrow Transplantation (BMT) is a useful strategy for the treatment of leukemia, severe combined immune deficiency, enzyme deficiencies, autoimmune disease, and osteoporosis . Furthermore, BMT plays an important role in the induction of immune tolerance in organ transplantation. Bone marrow is a spongy tissue, and is made up of Hematopietic Stem Cells (HSCs), Mesenchymal Stem Cells (MSCs), and various blood cells. HSCs differentiate into common myeloid- and lymphoid-precursor cells and then terminally differentiate into erythrocytes, monocytes, platelets, neutrophils, dendritic cells and other cells. MSCs can differentiate into not only mesoderm derived-cells such as adipocytes, osteoblasts, and osteoclasts, but also endodermand ectoderm-derived cells... View More»
    DOI: 10.4172/2329-6917.1000136

    Abstract PDF

Relevant Topics